Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01920815 · ClinicalTrials.gov registry record
Bicuspid Valve Aortopathy Feasibility Study
A clinical trial, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 500
- Enrollment target
NCT01920815: Completed study, sponsored by Oregon Health and Science University.
NCT01920815 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01920815 has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
Study Summary
In order to determine the effectiveness of medical therapy options to prevent enlargement of the aorta in patients with a bicuspid aortic valve, a randomized study will be planned. This feasibility study will gather accurate data on number needed to screen, changes in medication use over time, and variance of the intended study endpoint.
Primary Outcome
Patients will have a baseline and follow up MRI per a specific protocol to measure area of the ascending thoracic aorta. All measurements will be performed by a core imaging lab
Interventions
- OTHER No interventions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2013-07 |
| Est. Completion | 2017-10-04 |
What the finished NCT01920815 record still lists
NCT01920815 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No interventions is the first listed.
NCT01920815 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01920815 about?
NCT01920815 is a clinical study titled "Bicuspid Valve Aortopathy Feasibility Study". In order to determine the effectiveness of medical therapy options to prevent enlargement of the aorta in patients with a bicuspid aortic valve, a randomized study will be planned. This feasibility study will gather accurate data on number needed to screen, changes in medication use over time, and v...
What is the current status of trial NCT01920815?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2013-07. Estimated completion is 2017-10-04.
What interventions are being tested in trial NCT01920815?
The interventions under investigation include: No interventions (OTHER).
Who is sponsoring clinical trial NCT01920815?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia